Maternal serum concentrations of pregnancy associated placental protein A and pregnancy specific β-1-glycoprotein in multifetal pregnancies before and after fetal reduction

Human Reproduction

Volumn 11, Issue 4, 1996, Pages 900-902

  Abbas, Anthony ^a   Sebire, Neil J ^a   Johnson, Mark ^b   Bersinger, Nicholas ^c   Nicolaides, Kypros H ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Embryo reduction; Multifetal pregnancy; Pregnancy associated placental protein A; Pregnancy specific 1 glycoprotein

Indexed keywords

PLACENTA PROTEIN; PREGNANCY ASSOCIATED PROTEIN; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FERTILIZATION IN VITRO; FETUS; HUMAN; MATERNAL SERUM; MULTIPLE PREGNANCY; NORMAL HUMAN; PLACENTA FUNCTION; PLACENTA WEIGHT; TWIN PREGNANCY;

EID: 0029947429     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.humrep.a019275     Document Type: Article

References (16)

1. Abbas, A., Johnson, MR., Bersinger, N. and Nicolaides, K.H. (1994) Maternal serum alpha-fetoprotein in multifetal pregnancies before and after fetal reduction. Br. J. Obstet. Gynaecol., 101, 156-158
2. Abbas, A., Johnson, M.R., Chard, T. and Nicolaides, K.H. (1995) Maternal plasma insulin like growth factor binding protein-1 and placental protein 14 in multifetal pregnancies before and after fetal reduction. Hum. Reprod., 10, 207-210.
3. Bersinger, N. A., Brizot, M.L., Johnson, A. et al. (1994) First trimester maternal serum pregnancy associated placental protein A (PAPP-A) and pregnancy-specific beta-1-glycoprotein (SP-1) in fetal trisomies Br. J. Obstet. Gynaecol., 101, 156-158.
4. Bischof, P. (1989) Three pregnancy proteins (PP12, PP14 and PAPP-A): their biological and clinical relevance. Am. J. Perinatal, 6, 110-116.
5. Bischof, P. (1992) Pregnancy-associated plasma protein-A. Semin. Reprod. Endocrinol., 10, 127-134.
6. Bohn, H. (1974) Untersuchungen uber das Schwangerschafts-spezifische B1-Glykoprotein (SP1). Arch. Gynakol., 216, 347-358.
7. Evans, M.I., Goldberg, J.D., Dommergues, M. et al. (1994) Efficacy of second-trimester selective termination for fetal abnormalities, international collaborative experience among the world's largest centers. Am. J Obstet. Gynecol., 171, 90-94.
8. Gordon, Y.B., Grudzinskas, J.G., Jeffrey, D. and Chard, T. (1977) Concentrations of pregnancy-specific β1 glycoprotein in maternal blood in normal pregnancy and intrauterine growth retardation. Lancet. I, 331-335.
9. Johnson, M.R., Abbas, A. and Nicolaides, K.H. (1994a) Maternal plasma levels of hCG, oestradiol and progesterone in multifetal pregnancies before and after fetal reduction. J. Endocrinol., 143, 309-312
10. Johnson, M.R., Abbas, A., Allman, A.C.J., Nicolaides, K.H. and Lightman, S L. (1994b) The regulation of plasma relaxin levels during pregnancy. J. Endocrinol., 142, 261-265.
11. Lin, T.M. and Halbert, S.P. (1976) Placental localisation of human pregnancy associated plasma proteins. Science, 193, 1249-1252.
12. Lin, T.M., Halbert, S.P., Spellacy, W. and Gall, S. (1976) Human pregnancy-associated proteins during the postpartum period. Am. J. Obstet. Gynecol., 124, 382-387.
13. Rosen, S.W. (1986) New placental proteins: chemistry, physiology and clinical use. Placenta, 7, 575-594.
14. Schindler, A.M., Bordington, P. and Bischof, P. (1984) Immunohistochemical localisation of pregnancy-associated plasma protein A (PAPP-A) in decidua and trophoblast. Comparison with hCG and fibrin. Placenta, 45, 227-236.
15. Stabile, I., Grudzinskas, J.G. and Chard, T. (1988) Clinical applications of pregnancy protein estimations with particular reference to pregnancy-associated plasma protein A (PAPP-A). Obstet. Gynecol. Surv., 43, 73-82.
16. United States Department of Health Statistics and Research (SR28) (1993) Annual summaries of LHS 27/1 returns. United States Annual Vital Statistics Reports. Volume I. Natality, Department of Health.